Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate naltrexone as an adjunct in alcoholic cocaine dependent patients; concurrent relapse prevention theory.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
NCT07039175 · Tobacco Smoking, Alcohol-Related Disorders
NCT05910580 · Alcohol-Related Disorders, Substance-Related Disorders, and more
NCT06565429 · Family Members, Relatives, and more
NCT06916754 · Alcohol-Related Disorders, Alcoholism, and more
NCT05933226 · Human Immunodeficiency Virus, Alcohol-Related Disorders, and more
University of Texas Health Science Center
Houston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions